Literature DB >> 19135105

Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays.

Csilla Hegedus1, Gergely Szakács, László Homolya, Tamás I Orbán, Agnes Telbisz, Márton Jani, Balázs Sarkadi.   

Abstract

The major aim of this chapter is to provide a critical overview of the in vitro methods available for studying the function of the ABCG2 multidrug transporter protein. When describing the most applicable assay systems, in each case we present a short overview relevant to ABC multidrug transporters in general, and then we concentrate on the tools applicable to analysis of substrate-drug interactions, the effects of potential activators and inhibitors, and the role of polymorphisms of the ABCG2 transporter. Throughout this chapter we focus on recently developed assay systems, which may provide new possibilities for analyzing the pharmacological aspects of this medically important protein.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19135105     DOI: 10.1016/j.addr.2008.09.007

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  16 in total

Review 1.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

2.  Efflux and uptake transporters involved in the disposition of bazedoxifene.

Authors:  Tina Trdan Lušin; Aleš Mrhar; Bruno Stieger; Albin Kristl; Katja Berginc; Jurij Trontelj
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-29       Impact factor: 2.441

Review 3.  The role of transporters in toxicity and disease.

Authors:  John D Schuetz; Peter W Swaan; Donald J Tweedie
Journal:  Drug Metab Dispos       Date:  2014-04       Impact factor: 3.922

4.  Principles and Experimental Considerations for In Vitro Transporter Interaction Assays.

Authors:  Sid Bhoopathy; Chris Bode; Vatsala Naageshwaran; Erica Weiskircher-Hildebrandt; Venkata Mukkavilli; Ismael J Hidalgo
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

6.  Regulation of the function of the human ABCG2 multidrug transporter by cholesterol and bile acids: effects of mutations in potential substrate and steroid binding sites.

Authors:  Ágnes Telbisz; Csilla Hegedüs; András Váradi; Balázs Sarkadi; Csilla Özvegy-Laczka
Journal:  Drug Metab Dispos       Date:  2014-01-02       Impact factor: 3.922

7.  In vitro and in vivo modulation of ABCG2 by functionalized aurones and structurally related analogs.

Authors:  Hong-May Sim; Chung-Pu Wu; Suresh V Ambudkar; Mei-Lin Go
Journal:  Biochem Pharmacol       Date:  2011-08-17       Impact factor: 5.858

8.  Dimerization of ABCG2 analysed by bimolecular fluorescence complementation.

Authors:  Ameena J Haider; Deborah Briggs; Tim J Self; Hannah L Chilvers; Nicholas D Holliday; Ian D Kerr
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 9.  Pharmacological correction of misfolding of ABC proteins.

Authors:  Elena L Rudashevskaya; Thomas Stockner; Michael Trauner; Michael Freissmuth; Peter Chiba
Journal:  Drug Discov Today Technol       Date:  2014-06

10.  A new fluorescent dye accumulation assay for parallel measurements of the ABCG2, ABCB1 and ABCC1 multidrug transporter functions.

Authors:  Edit Szabó; Dóra Türk; Ágnes Telbisz; Nóra Kucsma; Tamás Horváth; Gergely Szakács; László Homolya; Balázs Sarkadi; György Várady
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.